NEW YORK (GenomeWeb) – Becton Dickinson today reported that its second quarter revenues increased around 4 percent year over year driven by growth in its BD Medical and BD Biosciences business segments.

BD reported total revenues of $2.07 billion for the three months ended March 31, up from $2.00 billion for the second quarter of 2013. It fell short of the average analyst estimate of $2.09 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.